MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
August 1, 2007
Ryan Fuhrmann
Foolish Forecast: CVS Caremark Gets Ready to Rumble CVS Caremark will announce its first combined quarterly results tomorrow. Competitors will be watching to see if the merger of drugstore chain and pharmacy benefit manager is a healthy one. mark for My Articles similar articles
The Motley Fool
May 8, 2007
Ryan Fuhrmann
CVS/Caremark Tie the Knot While it's too early to see if CVS blazed a new health-care trail by combining a drugstore chain with giant pharmacy benefit manager Caremark, there are still interesting tidbits to pass along to investors from recently reported results. mark for My Articles similar articles
The Motley Fool
April 9, 2007
Mike Cianciolo
CVS: Continued Vigorous Sales The drugstore chain grows sales and itself in March. Investors, take note. mark for My Articles similar articles
The Motley Fool
November 2, 2006
Ryan Fuhrmann
CVS Blazes a New Healthcare Trail Strong third-quarter earnings aside, the merger announcement with pharmacy benefit manager Caremark was the real shocker here. Investors, take note. mark for My Articles similar articles
The Motley Fool
August 31, 2011
Shubh Datta
CVS Caremark Flattened by Higher Costs CVS Caremark profits remained relatively flat this quarter despite a substantial increase in revenue. mark for My Articles similar articles
The Motley Fool
June 10, 2004
Alyce Lomax
Summer Starts at CVS The drugstore company releases same-store sales results on the cusp of its Eckerd acquisition. mark for My Articles similar articles
The Motley Fool
October 2, 2011
Shubh Datta
Would You Invest in This Drug Retailer? Is CVS Caremark worth your investment? mark for My Articles similar articles
The Motley Fool
September 22, 2006
Ryan Fuhrmann
More in Store at Rite Aid? The retail pharmacy posted strong second-quarter sales, and an acquisition could help long-term results. Investors, take note. mark for My Articles similar articles
The Motley Fool
January 8, 2007
Matthew Crews
CVS' Tightrope Walk The drugstore chain's aggressive growth strategy continues to pay off -- for now. Investors, take note. mark for My Articles similar articles
The Motley Fool
July 5, 2005
Alyce Lomax
Business As Usual at Walgreen Walgreen's same-store sales for June certainly don't disappoint. Investors might question whether the retail pharmacy can keep up the great work. mark for My Articles similar articles
The Motley Fool
September 26, 2006
Ryan Fuhrmann
Jaw-Dropping Pill-Popping at Walgreen How much longer can investors count on Walgreen's stellar numbers? mark for My Articles similar articles
The Motley Fool
March 26, 2010
Cathy Applefeld Olson
Can CVS Caremark Win the Drug Wars? Now that health-care legislation has been signed into law, it's a perfect time to give the country's largest drugstore chain a checkup. mark for My Articles similar articles
The Motley Fool
June 29, 2006
Ryan Fuhrmann
Walgreen's Prescription for Growth The drugstore chain continues to roll, even if it is a bit pricey. Great companies rarely trade at bargain-basement levels. But if savvy investors keep a watchful eye, they may find an opportunity to pick up some shares at a fairer price. mark for My Articles similar articles
The Motley Fool
February 2, 2007
Ryan Fuhrmann
Uncertain Outlook on CVS Has the retail pharmacy bit off more than it can chew? Investors may soon look back longingly to the day when CVS focused as much on organic, or internal, means to grow its business as it does on acquisitions to buy outside market share. mark for My Articles similar articles
The Motley Fool
June 10, 2010
Claire Stephanic
CVS Caremark vs. Walgreen The two go head-to-head in competition for pharmacy customers. mark for My Articles similar articles
The Motley Fool
September 14, 2006
Ryan Fuhrmann
Playing Defense With the Drugstore Industry Retail pharmacy August sales trends help investors discern the leader in this appealing sector. mark for My Articles similar articles
The Motley Fool
October 5, 2007
Timothy M. Otte
CVS: Consistently Very Solid The drugstore giant scores a consistent sales increase in September, as it begins to capitalize on synergies from its CareMark acquisition. mark for My Articles similar articles
The Motley Fool
March 22, 2010
Dave Mock
A Big Upgrade for CVS Caremark This bullish call comes from more than just one analyst. mark for My Articles similar articles
The Motley Fool
February 4, 2008
Timothy M. Otte
CVS Has Major Mo' Fourth-quarter results cap a stellar year for the drugstore retailer. mark for My Articles similar articles
The Motley Fool
March 26, 2007
Ryan Fuhrmann
A Healthy Shade of Walgreen: Fool by Numbers The drugstore chain released second-quarter 2007 results: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
December 19, 2006
Matthew Crews
Express Scripts' Takeover Battle The pharmacy benefits manager challenges CVS with a higher bid for rival Caremark RX. Investors, stay tuned -- this is far from over. mark for My Articles similar articles
The Motley Fool
June 2, 2004
Alyce Lomax
Walgreen's Mellow May Will the drugstore chain get a taste of its own medicine? mark for My Articles similar articles
The Motley Fool
March 26, 2007
Ryan Fuhrmann
Addicted to Growth at Walgreen Walgreen is a steady grower, but that comes at a price. Investors, take note. mark for My Articles similar articles
The Motley Fool
June 2, 2011
Dee Gill
CVS's Improved Performance Begins to Drown Out the Dump-Caremark Chants Is the prognosis for CVS looking up? mark for My Articles similar articles
The Motley Fool
July 14, 2008
Rick Aristotle Munarriz
4 Stocks That Took a Hike These stocks recently raised their dividends: CVS Caremark... Paychex... Walgreen... Cummins... mark for My Articles similar articles
The Motley Fool
October 8, 2011
Shubh Datta
Impasse Hurts Walgreen's Quarter Walgreen posted a staggering 69% earnings jump but still saw its shares slide. mark for My Articles similar articles
The Motley Fool
July 27, 2004
Brian Gorman
Medco's Pumped About Generics Generic drugs are actually helping improve Medco's margins, making it a winner with investors and health-care plans. mark for My Articles similar articles
The Motley Fool
July 6, 2007
Mike Cianciolo
Walgreen: The New Deal Maker Walgreen announces its latest acquisition as it tries to keep pace with the competition. Investors, take note. mark for My Articles similar articles
The Motley Fool
July 6, 2007
Lawrence Rothman
Walgreen Does It Again The company continues to impress, posting positive same-store sales results month after month. At a P/E of 21, this stock isn't especially rich, given the solid performance that the company delivers. mark for My Articles similar articles
The Motley Fool
July 6, 2004
Alyce Lomax
Not Ready for Rite Aid Can the drugstore chain hold a candle to the competition? Its shares are trading at 22 times forward earnings, making it a seemingly less-than-advantageous time to place a bet on them. mark for My Articles similar articles
The Motley Fool
June 11, 2007
Mike Cianciolo
Rite Aid's Generic Sales The drugstore chain gradually increases sales, and catches up to the big boys in one way. Investors, take note. mark for My Articles similar articles
The Motley Fool
July 6, 2004
Steven Mallas
Walgreen's Sunny Sales The retail pharmacy has a resplendently ruddy June, with comp sales increasing more than 10%. mark for My Articles similar articles
The Motley Fool
July 6, 2007
Timothy M. Otte
Drugstore Sales Remain Healthy The big four drugstore chains report higher comparable sales in June. Walgreen... CVS... Rite Aid... Long's... mark for My Articles similar articles
The Motley Fool
March 9, 2004
Alyce Lomax
February Frenzy at CVS, Rite Aid The flu season's early end hasn't stopped drugstore retailers. mark for My Articles similar articles
The Motley Fool
May 2, 2008
Timothy M. Otte
CVS Caremark and the Snickers Factor The soft economy has hit some retail sectors hard. But there are still pockets of life, and CVS Caremark is one of the companies leading the way. mark for My Articles similar articles
The Motley Fool
January 7, 2010
Gerard Torres
Walgreen Lives to Fight Another Day Despite recent success, Walgreen continues to face stiff competition. mark for My Articles similar articles
The Motley Fool
November 5, 2007
Timothy M. Otte
CVS Is in the Zone Pharmacy giant CVS grew EPS by 36% in the third quarter. The company has been on a roll since its merger with Caremark last year. mark for My Articles similar articles
The Motley Fool
June 25, 2007
Ryan Fuhrmann
Foolish Forecast: Rite Aid Aims for Healthy Growth The drugstore operator is set to report its first-quarter earnings. Investors, here is what you can expect to see. mark for My Articles similar articles
The Motley Fool
June 26, 2007
Ryan Fuhrmann
Walgreen Sells Convenience Walgreen continues to grow market share, with little sign of slowing down. mark for My Articles similar articles
The Motley Fool
January 5, 2007
Matthew Crews
Rite Aid's Baby Steps If Rite Aid does manage 5% operating margins, this pharmacy chain's shares will get the love they deserve. mark for My Articles similar articles
The Motley Fool
June 30, 2011
David Williamson
Pharmacy Benefits Delivering Drama CVS claims another Medco client and one messy split. mark for My Articles similar articles
BusinessWeek
September 19, 2005
Gene G. Marcial
CVS' Ever-Expanding Aisles According to analysts, the aging population and improving pipeline of new drugs will help the retail pharmacy achieve its goal of 15% overall long-term earnings growth. Investors, take note. mark for My Articles similar articles
The Motley Fool
January 3, 2005
Nathan Slaughter
Walgreen Seeing Green Rivals CVS and Rite Aid have a bitter pill to swallow as Walgreen stays strong. While Walgreen's revenues were in line with forecasts, the stronger-than-expected bottom line has the stock gaining ground. mark for My Articles similar articles
The Motley Fool
February 14, 2005
Brian Gorman
GM Pulls Out of Walgreen The pharmacy's mail-order policy spurs the automaker's cost-containment decision. mark for My Articles similar articles
The Motley Fool
February 2, 2005
Alyce Lomax
CVS's Shot in the Arm Buying the Eckerd drugstore chain from J.C. Penney was apparently a good move for CVS. It continues to benefit from the purchase, reporting positive earnings and beating analysts' expectations by a penny. mark for My Articles similar articles
The Motley Fool
June 14, 2010
Jennifer Schonberger
The S&P 500's Biggest Movers Gannett was among the companies making a move up. mark for My Articles similar articles
The Motley Fool
August 16, 2007
Lawrence Rothman
Longs' Prescription for Success Longs Drug Stores may be small, but it excels in its regional niche. Operating primarily on the West Coast, second-quarter results show a company with lots of room for growth. mark for My Articles similar articles
The Motley Fool
April 29, 2010
Brian Orelli
A Prescription to Investigate Further Let's not worry just yet about Medco's margins. mark for My Articles similar articles
The Motley Fool
November 10, 2004
Dave Marino-Nachison
Investors Adjusting to Larger CVS The drugstore company's chains have done nothing but rise since the Eckerd buy. Investors have pulled the company's shares steadily upward since the merger closed. mark for My Articles similar articles
The Motley Fool
June 2, 2011
Seth Jayson
One Reason the Street Should Love CVS Caremark's Earnings With both 12-month and quarterly CCC running better than average, CVS Caremark gets high marks in this cash-conversion checkup. mark for My Articles similar articles